{"id":4127,"date":"2019-02-19T17:35:16","date_gmt":"2019-02-19T12:05:16","guid":{"rendered":"https:\/\/www.delveinsight.com\/blog\/?p=4127"},"modified":"2021-07-24T12:57:13","modified_gmt":"2021-07-24T07:27:13","slug":"notizia-91","status":"publish","type":"post","link":"https:\/\/www.delveinsight.com\/blog\/notizia-91","title":{"rendered":"Notizia"},"content":{"rendered":"\n

CRISPR treatment delivers benefits in mice<\/strong><\/p>\n\n\n\n


The researchers from Duke University<\/strong> along with drugmaker Sarepta Therapeutics<\/strong> published a report stating that a single change in the genetic system of Duchenne muscular dystrophy (DMD)<\/a><\/strong> affected mice, using CRISPR <\/strong>gene editing tool resulted in increasing their life span by one year. No toxic immune responses were exhibited to Cas9 enzyme<\/strong> used for gene editing<\/strong>. <\/p>\n\n\n\n

A step ahead in treating metastatic Kidney Cancer<\/strong><\/p>\n\n\n\n

Drug makers Merck & Co.<\/strong> and Pfizer<\/strong> conducted trials giving thumbs up to pair immunotherapy<\/strong> with a type of targeted drug to treat metastatic Kidney Cancer.<\/a><\/strong> In trials, patients who received Merck’s Keytruda<\/strong> and Pfizer’s Bavencio<\/strong> together showed increased chances of survival as compared to those given only Sutent<\/strong>. <\/p>\n\n\n\n

University<\/strong><\/g> of Louisville develops a drug to target <\/strong>tumors<\/strong><\/g><\/p>\n\n\n\n


Researchers at University of Louisville <\/strong>have developed a drug SA-4-1BBL,<\/strong> which when used in concurrence with adaptive T-cells<\/a><\/strong> can largely shield from tumors<\/g>. The novel drug activates CD4+ T cells<\/strong> and Natural Killer cells <\/strong>which have the power to destroy the cancer<\/g><\/g> causing<\/g> cells in the body even before they get settled. <\/p>\n\n\n\n

Bayer and Orion <\/strong>develop<\/strong><\/g> a therapy to beat Prostate Cancer<\/strong><\/p>\n\n\n\n


Drug makers Bayer<\/strong> and Orion <\/strong>are jointly developing a therapy to enhance metastasis-free survival. Trials were conducted, which revealed that when Darolutamide<\/strong> added with Androgen Deprivation Therapy (ADT)<\/strong>, showed 59 <\/strong>percent<\/strong><\/g> <\/strong>decline in the probability of deaths caused than in Placebo with ADT in the patients affected by Prostate Cancer<\/a><\/strong>.<\/p>\n","protected":false},"excerpt":{"rendered":"

CRISPR treatment delivers benefits in mice The researchers from Duke University along with drugmaker Sarepta Therapeutics published a report stating that a single change in the genetic system of Duchenne muscular dystrophy (DMD) affected mice, using CRISPR gene editing tool resulted in increasing their life span by one year. No toxic immune responses were exhibited […]<\/p>\n","protected":false},"author":1,"featured_media":4047,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_editorskit_title_hidden":false,"_editorskit_reading_time":0,"_editorskit_is_block_options_detached":false,"_editorskit_block_options_position":"{}","advgb_blocks_editor_width":"","advgb_blocks_columns_visual_guide":"","footnotes":""},"categories":[32],"tags":[137,2582,2295,1079,460,498,2581],"industry":[17225],"therapeutic_areas":[17235,17238,17228,17234],"class_list":["post-4127","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-notizia","tag-cancer","tag-cas9-enzyme","tag-duke-university","tag-natural-killer-cells","tag-pfizer","tag-prostate-cancer","tag-sarepta-therapeutics","industry-pharmaceutical","therapeutic_areas-cell-and-gene-therapy","therapeutic_areas-genetic-disorders","therapeutic_areas-oncology","therapeutic_areas-rare-diseases"],"acf":[],"yoast_head":"\nNotizia 19\/02\/2019 - DelveInsight Business Research LLP<\/title>\n<meta name=\"description\" content=\"Merck & Co. and Pfizer conducted trials giving thumbs up to pair immunotherapy with a type of targeted drug to treat metastatic Kidney Cancer...\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.delveinsight.com\/blog\/notizia-91\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Notizia 19\/02\/2019 - DelveInsight Business Research LLP\" \/>\n<meta property=\"og:description\" content=\"Merck & Co. and Pfizer conducted trials giving thumbs up to pair immunotherapy with a type of targeted drug to treat metastatic Kidney Cancer...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.delveinsight.com\/blog\/notizia-91\" \/>\n<meta property=\"og:site_name\" content=\"DelveInsight Business Research\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/\" \/>\n<meta property=\"article:published_time\" content=\"2019-02-19T12:05:16+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-07-24T07:27:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2019\/02\/09021655\/drugs.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"759\" \/>\n\t<meta property=\"og:image:height\" content=\"422\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"DelveInsight\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:site\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"DelveInsight\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Notizia 19\/02\/2019 - DelveInsight Business Research LLP","description":"Merck & Co. and Pfizer conducted trials giving thumbs up to pair immunotherapy with a type of targeted drug to treat metastatic Kidney Cancer...","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.delveinsight.com\/blog\/notizia-91","og_locale":"en_US","og_type":"article","og_title":"Notizia 19\/02\/2019 - DelveInsight Business Research LLP","og_description":"Merck & Co. and Pfizer conducted trials giving thumbs up to pair immunotherapy with a type of targeted drug to treat metastatic Kidney Cancer...","og_url":"https:\/\/www.delveinsight.com\/blog\/notizia-91","og_site_name":"DelveInsight Business Research","article_publisher":"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/","article_published_time":"2019-02-19T12:05:16+00:00","article_modified_time":"2021-07-24T07:27:13+00:00","og_image":[{"width":759,"height":422,"url":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2019\/02\/09021655\/drugs.jpg","type":"image\/jpeg"}],"author":"DelveInsight","twitter_card":"summary_large_image","twitter_creator":"@DelveInsight","twitter_site":"@DelveInsight","twitter_misc":{"Written by":"DelveInsight","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.delveinsight.com\/blog\/notizia-91","url":"https:\/\/www.delveinsight.com\/blog\/notizia-91","name":"Notizia 19\/02\/2019 - DelveInsight Business Research LLP","isPartOf":{"@id":"https:\/\/www.delveinsight.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.delveinsight.com\/blog\/notizia-91#primaryimage"},"image":{"@id":"https:\/\/www.delveinsight.com\/blog\/notizia-91#primaryimage"},"thumbnailUrl":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2019\/02\/09021655\/drugs.jpg","datePublished":"2019-02-19T12:05:16+00:00","dateModified":"2021-07-24T07:27:13+00:00","author":{"@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/5fbf6ca478835d03fdb5e17d905b520a"},"description":"Merck & Co. and Pfizer conducted trials giving thumbs up to pair immunotherapy with a type of targeted drug to treat metastatic Kidney Cancer...","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.delveinsight.com\/blog\/notizia-91"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/notizia-91#primaryimage","url":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2019\/02\/09021655\/drugs.jpg","contentUrl":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2019\/02\/09021655\/drugs.jpg","width":759,"height":422,"caption":"Kidney Cancer"},{"@type":"WebSite","@id":"https:\/\/www.delveinsight.com\/blog\/#website","url":"https:\/\/www.delveinsight.com\/blog\/","name":"DelveInsight Business Research","description":"Blog","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.delveinsight.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/5fbf6ca478835d03fdb5e17d905b520a","name":"DelveInsight","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/afdd550c64e18f6ad8957080b017c6ae55f4916951d641d3cd40264176aa0e86?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/afdd550c64e18f6ad8957080b017c6ae55f4916951d641d3cd40264176aa0e86?s=96&d=mm&r=g","caption":"DelveInsight"}}]}},"author_meta":{"display_name":"DelveInsight","author_link":"https:\/\/www.delveinsight.com\/blog\/author\/gtadmin"},"featured_img":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2019\/02\/09021655\/drugs-300x167.jpg","coauthors":[],"tax_additional":{"categories":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/notizia\/\" class=\"advgb-post-tax-term\">Notizia - Recent Pharma, Healthcare and Biotech Happenings<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Notizia - Recent Pharma, Healthcare and Biotech Happenings<\/span>"]},"tags":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/notizia\/\" class=\"advgb-post-tax-term\">Cancer<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/notizia\/\" class=\"advgb-post-tax-term\">Cas9 enzyme<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/notizia\/\" class=\"advgb-post-tax-term\">Duke University<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/notizia\/\" class=\"advgb-post-tax-term\">Natural killer cells<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/notizia\/\" class=\"advgb-post-tax-term\">Pfizer<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/notizia\/\" class=\"advgb-post-tax-term\">Prostate Cancer<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/notizia\/\" class=\"advgb-post-tax-term\">Sarepta Therapeutics<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Cancer<\/span>","<span class=\"advgb-post-tax-term\">Cas9 enzyme<\/span>","<span class=\"advgb-post-tax-term\">Duke University<\/span>","<span class=\"advgb-post-tax-term\">Natural killer cells<\/span>","<span class=\"advgb-post-tax-term\">Pfizer<\/span>","<span class=\"advgb-post-tax-term\">Prostate Cancer<\/span>","<span class=\"advgb-post-tax-term\">Sarepta Therapeutics<\/span>"]}},"comment_count":"0","relative_dates":{"created":"Posted 7 years ago","modified":"Updated 5 years ago"},"absolute_dates":{"created":"Posted on Feb 19, 2019","modified":"Updated on Jul 24, 2021"},"absolute_dates_time":{"created":"Posted on Feb 19, 2019 5:35 pm","modified":"Updated on Jul 24, 2021 12:57 pm"},"featured_img_caption":"Kidney Cancer","series_order":"","_links":{"self":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/4127","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/comments?post=4127"}],"version-history":[{"count":0,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/4127\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media\/4047"}],"wp:attachment":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media?parent=4127"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/categories?post=4127"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/tags?post=4127"},{"taxonomy":"industry","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/industry?post=4127"},{"taxonomy":"therapeutic_areas","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/therapeutic_areas?post=4127"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}